Brivissa 50 Tablet
Marketer
Arinna Lifescience Pvt Ltd
Salt Composition
Brivaracetam (50mg)
Overview Brivissa 50 Tablet
Epileptic seizures are managed with the anticonvulsant Brivissa 50mg tablets. This medication, used either independently or in conjunction with other treatments, effectively controls seizures as long as the prescribed regimen is followed. Brivissa 50mg works by reducing abnormal brain electrical activity. Administer regularly, with or without food, consistently at the same time daily for optimal efficacy. Dosage and frequency are determined by your physician to achieve optimal seizure control and may be gradually adjusted. Long-term use is generally recommended; continue taking this medication as directed, even if you feel well, as discontinuation or missed doses may exacerbate seizures. Never cease treatment without your doctor's instruction; abrupt cessation can worsen seizures. Common side effects, including dizziness, headache, nausea, and vomiting, are often observed, alongside possible behavioral alterations such as aggression or irritability. These are usually more pronounced initially, diminishing with continued use. While many side effects are minor, some require medical attention. Suicidal ideation has been reported in a small percentage of patients; inform your doctor of any mood deterioration. Prior to commencing treatment, disclose any pre-existing liver or kidney issues, depression, suicidal thoughts, pregnancy, or pregnancy plans. Nursing mothers should also seek medical counsel before use.
Primary Ingredients of Brivissa 50 Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Brivissa 50 Tablet
Convulsive disorders
Major Benefits of Brivissa 50 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The tablet should be swallowed whole; avoid chewing, crushing, or breaking it. Brivissa 50 Tablets can be administered with or without food, although consistent timing is recommended.
Common Side effects of Brivissa 50 Tablet:
- Behavioral changes
- Agitation
- Aggressive behavior
- Dizziness
- Sedation
- Drowsiness
- Neuropsychiatric symptoms
How to use Brivissa 50 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Brivissa 50 Tablet whole; avoid chewing, crushing, or breaking it. This medication can be taken with or without food, though consistent timing is recommended.
How Brivissa 50 Tablet works:
Brivissa 50mg tablets are used to treat epilepsy. Their mechanism of action involves binding to SV2A receptors located on neuronal membranes. This binding reduces excessive neuronal activity in the brain, thereby preventing the propagation of seizure-inducing electrical impulses.
SAFETY ADVICE
AlcoholUNSAFE
Combining Brivissa 50 Tablet and alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Brivissa 50 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Brivissa 50 Tablet with breastfeeding is currently unavailable. Seek medical advice from your physician.
DrivingUNSAFE
Taking Brivissa 50 Tablet might reduce attentiveness, impair vision, or induce drowsiness and dizziness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
Brivissa 50 Tablet is considered safe for individuals with kidney disease, and no dosage alteration is suggested. However, its use is not advised in cases of end-stage renal disease given the absence of supporting clinical trial data.
LiverCAUTION
For individuals with hepatic impairment, Brivissa 50 mg tablets require careful administration. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Brivissa 50 Tablet :
NA
Facts to Know About Brivissa 50 Tablet
| Label | Value |
|---|---|
| Chemical Type | Levetiracetam Analog |
| Developing Habits | No. |
| Treatment Category | Neuroscience Central Nervous System |
| Actions | AED, a protein ligand, within synaptic vesicle 2 |



